In this context, a nutriepigenetic pilot study is being conducted to evaluate how a personalized nutritional and lifestyle intervention (NLI) can modulate expression of blood and salivary miRNAs associated with breast cancer risk in unaffected young women (<40 years) with BRCA1/2 mutations (19, 102). The gene discussed is BRCA1; the disease is breast cancer.